Good morning, here is what I’m reading today:
- And so it continues…Biopharma IPOs gone wild: Highest amount ever raised as 14 companies join public ranks (Clarivate)
- Not all news about Pfizer is about drug pricing, they will also be reorganizing into three distinct business units (BioPharma Dive).
- Not all money is being raised on the public markets – Healthcare VC Investing Could Hit A Record High In 2018 (Forbes).
- How value-based care and oncology come together in the healthcare ecosystem (MedCity News).